January 17, 2018 PR-M01-18-NI-048
Croda International PLC (CRDA.LN) said Thursday that it had bought two separate companies — a Canadian marine biotechnology company and a technology supplier headquartered in Finland — for an undisclosed fee.
The U.K.-listed chemicals producer said it bought Nautilus Biosciences Canada Inc. to implement its marine microbial biodiversity science across all of Croda's market sectors.
Croda also said it intends to establish an innovation center for marine biotechnology at Nautilus's existing base at the University of Prince Edward Island.
The second acquisition, Finnish company IonPhasE Oy, is a supplier of static-electricity protection products that operates within the plastics market, Croda said.
The purchases bring Croda's number of technology acquisitions and co-investments completed in the last year to four, the company said.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.